Chronic infection containment {#cesec10}
=============================

Long-lived memory lymphocytes generate short-lived terminal progeny and also replenish the long-lived memory pool upon reinfection. Chronic viral infections strain the renewal capacity of antiviral T-cell populations, however, which can lead to failure of long-term immunity. Researchers [have now identified](10.1126/science.1229620) two distinct subsets of antiviral CD8 T cells in mice that are characterised by differential expression of the T-bet and Eomesodermin transcription factors and that cooperate to contain chronic viral infections. Further characterisation of these progenitor and terminal T-cell subsets could suggest ways to improve the regenerative capacity of antiviral T cells during chronic infections.

Cows, badgers, and tuberculosis {#cesec20}
===============================

Badgers (*Meles meles*) are an important wildlife reservoir of *Mycobacterium bovis*, a pathogen of economic and animal health importance that might also contribute to human tuberculosis. However, despite extensive research, the involvement of badgers in *M bovis* transmission remains controversial. Researchers have now used whole-genome sequencing and [mathematical modelling](10.1371/journal.ppat.1003008) to investigate local transmission patterns of *M bovis* in cattle and badgers on neighbouring farms in Northern Ireland. Their results provide the first direct genetic evidence of *M bovis* persistence on farms across several outbreaks and of a continuing interaction with local badgers, but do not show the directionality of transmission.
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"And now the 'flu forecast" {#cesec30}
===========================

Our ability to predict local seasonal influenza outbreaks is currently very limited. However, in a [new study](10.1073/pnas.1208772109), researchers use a data assimilation technique that is often used in numerical weather prediction to develop a framework that can turn real-time, web-based estimates of influenza infection rates into local influenza forecasts. A test of the framework that uses data from the 2003--08 New York influenza seasons shows that the approach allows real-time predictions of the timing of peak influenza infections to be made more than 7 weeks ahead of the actual peak.

mRNA influenza vaccines {#cesec40}
=======================

At present, it takes several months to design and manufacture a new influenza vaccine. As a result, it is hard to produce an adequate vaccine supply when a pandemic influenza strain emerges. Vaccines based on mRNA, which could be made in weeks, might offer a solution, according to the investigators of a [new study](10.1038/nbt.2436). In the study, mRNA vaccines induced long-lived protective immunity in mice of all ages, including very young and very old animals, and immunological correlates of immunity in ferrets and pigs. The vaccines also had protective effects in pigs similar to those of a licensed vaccine.

Cytomegalovirus decoded {#cesec50}
=======================

The human cytomegalovirus (HCMV) genome was sequenced 20 years ago, but its protein coding potential is incompletely understood. Now, researchers have used ribosome profiling and transcript analysis to define the HMCV translation products and to follow their temporal expression. They identify hundreds of previously unidentified open reading frames. They also show that regulated use of alternative transcript sites is involved in the temporal control of HMCV protein expression and in the generation of multiple polypeptides from individual genomic loci, thereby revealing an unexpected complexity in the HMCV genome.

New human coronavirus {#cesec60}
=====================

Researchers have fully characterised the genome of [HCoV-EMC/2012](10.1126/science.1227919), a coronavirus that was isolated from a man who died after developing acute pneumonia and organ failure in Saudi Arabia in June, 2012. Phylogenetic analysis of the replicase gene of this virus and of other sequenced coronaviruses suggests that HCoV-EMC/2012 is most closely related to two coronaviruses isolated in Asia from bats. The analysis also suggests that HCoV-EMC/2012 is the first human coronavirus in lineage C of the genus Betacoronavirus.

Antibiotic screening {#cesec70}
====================

Antibiotic activity profile screening ("BioMAP" screening) could streamline the search for natural product antibiotics. [Researchers](10.1016/j.chembiol.2012.09.014) used a panel of 15 clinically relevant bacterial strains to create unique biological fingerprints for a training set of 72 commercially available antibiotics. BioMAP screening accurately predicted the presence of known antibiotics in natural product extracts and, additionally, identified a structurally unique naphthoquinone-based antibiotic (arromycin) in a marine natural product library, a discovery that validates the BioMAP approach.

For more on the **genomic characterisation of a new human coronavirus** see *MBio* 2012; **3:** e00473-12; DOI:10.1128/mBio.00473-12
